The tribunal sanctioned the scheme of amalgamation through an order pronounced on March 27, 2025.
The company noted that the effective date will be communicated to the stock exchanges for public disclosure as per applicable regulations.
As per the scheme’s terms, the merger will take effect from the first business day of the month following the fulfilment of all conditions, including approval from the Department of Pharmaceuticals, if required.
The story "NCLT approves amalgamation of Suven Pharma, Cohance Lifesciences" has 341 words across 11 sentences, which will take approximately 2 - 3 minutes for the average person to read.
Which news outlet covered this story?
The story "NCLT approves amalgamation of Suven Pharma, Cohance Lifesciences" was covered 5 days ago by Business Standard, a news publisher based in India.
How trustworthy is 'Business Standard' news outlet?
Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.
The outlet is headquartered in India and publishes an average of 292 news stories per day.
It's most recent story was published 4 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
